staff Archives - PBD Biotech

TB blood-test developers PBD Biotech appoint Dr Marie Roskrow as Chair

January 17, 2023

Identifying those most at risk of active TB disease becomes a priority as fatalities increase. In response to this need, PBD Biotech is announcing that it has appointed Dr Marie Roskrow to chair its board and has expanded its scientific...

TB blood-test developers PBD Biotech appoint Dr Marie Roskrow as Chair

January 17, 2023

Identifying those most at risk of active TB disease becomes a priority as fatalities increase. In response to this need,...

PBD Biotech expands its North American operations

January 27, 2022

PBD Biotech is expanding its North American team. Tuberculosis (TB) and Johne’s Disease expert Tom Kellner has been appointed as Director of Operations in North America, to advise on regulatory affairs and provide technical and customer support.

PBD Biotech expands its North American operations

January 27, 2022

PBD Biotech is expanding its North American team. Tuberculosis (TB) and Johne’s Disease expert Tom Kellner has been appointed as...

Disruptive phage technology attracts top scientist to PBD Biotech

January 18, 2022

“PBD Biotech has developed an exciting and potentially disruptive technology that uses bacteriophage to improve the molecular diagnosis of tuberculosis” says Dr Tomas Richardson.

Disruptive phage technology attracts top scientist to PBD Biotech

January 18, 2022

“PBD Biotech has developed an exciting and potentially disruptive technology that uses bacteriophage to improve the molecular diagnosis of tuberculosis”...